Prosecution Insights
Last updated: April 19, 2026
Application No. 17/906,475

METHOD FOR PREPARING INTERMEDIATE FOR USE IN SYNTHESIS OF FLORFENICOL AND COMPOUNDS PREPARED THEREBY

Non-Final OA §112
Filed
Sep 16, 2022
Examiner
SAWYER, JENNIFER C
Art Unit
1691
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Heading (Nanjing) Pharmtechnologies Co. Ltd.
OA Round
1 (Non-Final)
69%
Grant Probability
Favorable
1-2
OA Rounds
2y 9m
To Grant
58%
With Interview

Examiner Intelligence

Grants 69% — above average
69%
Career Allow Rate
375 granted / 545 resolved
+8.8% vs TC avg
Minimal -11% lift
Without
With
+-10.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
45 currently pending
Career history
590
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
43.9%
+3.9% vs TC avg
§102
19.4%
-20.6% vs TC avg
§112
24.7%
-15.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 545 resolved cases

Office Action

§112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Detailed Action This office action is in response to applicant’s communication filed on 8/20/25. Claims 1-16 are pending in this application. The examiner attempted to contact the attorney of record, Xia Li, at 352-871-8920, multiple times on 10/15/25 and 10/16/25, but was unsuccessful. The examiner heard this automated response “The mailbox is full and can not accept any messages at this time.” Applicant’s election without traverse of Group 1, claims 1-6 and 9-16 in the reply filed on 8/20/25 is acknowledged. Thus claims 7-8 are withdrawn from further consideration being drawn to the nonelected invention. As a result, claims 1-6 and 9-16 are being examined in this Office Action. Priority The applicant claims benefit as follows: PNG media_image1.png 228 612 media_image1.png Greyscale Objections Claims 1-3, 5-6, 12 and 14 are objected to because of the following informalities: For clarity, the applicant should add parenthesis around the letters A, B, C, D and TM and the number 1, since they represent compounds in the claims. This change would look like: (A), (B), (C), (D), (TM) and (1). This should be done underneath the compounds in the reaction scheme and underneath the catalyst structure in claim 1, and throughout the claim language in claims 1-3, 5-6, 12 and 14. The examiner also suggests a change to claim 1 from “A method for preparing and intermediate of formula TM of florfenicol, comprising the following synthetic route:” to “A method for preparing formula (TM), an intermediate of florfenicol, comprising the following synthetic route:”, for clarity. The examiner also suggests a change to claim 1, in which the “workup” language is removed. Thus changing the claim language in claim 1 from “adding a catalyst to proceed a catalysis reaction; performing workup by adding a first acid after the catalysis reaction is ended; filtering out the precipitated solids after the workup, and concentrating the filtrate” to “adding a catalyst to proceed a catalysis reaction; adding a first acid after the catalysis reaction is ended; filtering out the precipitated solids, and concentrating the filtrate”, for clarity. The examiner also suggests a change to claim 1 from “R is selected from methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert- butyl” to “R is selected from methyl, ethyl, propyl, isopropyl, butyl, isobutyl or tert- butyl”, to align with proper Markush language. Appropriate correction is required. Claim Rejections – 35 USC 112.2 The following is a quotation of the second paragraph of 35 U.S.C. 112: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-6 and 9-16 are rejected under 35 U.S.C. 112, second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which applicant regards as the invention. Claim 1 recites "the precipitated solids” in step (1). There is no antecedent basis for "precipitated solids” earlier in claim 1. The dependent claims are rejected as being dependent on a rejected claim. Appropriate correction is required. Conclusion No claim is allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Jennifer Cho Sawyer whose telephone number is (571) 270 1690. The examiner can normally be reached on Monday-Friday 9 AM - 6 PM PST. If attempts to reach the examiner by telephone are unsuccessful, the examiner's supervisor, Renee Claytor can be reached on (571) 272-8394. The fax phone number for the organization where this application or proceeding is assigned is 571-274-1690. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. Jennifer Cho Sawyer Patent Examiner Art Unit: 1691 /RENEE CLAYTOR/Supervisory Patent Examiner, Art Unit 1691
Read full office action

Prosecution Timeline

Sep 16, 2022
Application Filed
Oct 16, 2025
Non-Final Rejection — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12552735
PROCESS FOR THE SYNTHESIS OF TWIN-TAIL TRIAMINES
2y 5m to grant Granted Feb 17, 2026
Patent 12552753
Methods and Compositions for Targeting Tregs using CCR8 Inhibitors
2y 5m to grant Granted Feb 17, 2026
Patent 12528758
PRODUCTION OF AROMATIC ACIDS AND PHENOLICS
2y 5m to grant Granted Jan 20, 2026
Patent 12528765
CONTINUOUS SYNTHESIS METHOD OF 2-ACETAMIDO-5-NITROANISOLE
2y 5m to grant Granted Jan 20, 2026
Patent 12509417
ENANTIOSELECTIVE PROCESS
2y 5m to grant Granted Dec 30, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
69%
Grant Probability
58%
With Interview (-10.6%)
2y 9m
Median Time to Grant
Low
PTA Risk
Based on 545 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month